Target intelligence / Profile preview

Mammalian ribosome (80S ribosome)

Target
80S ribosome
Molecular classification
Enzyme, Other
01

Overview

The mammalian ribosome is a complex macromolecular machine responsible for translating messenger RNA (mRNA) into proteins, a fundamental process for cellular survival, growth, and proliferation. Structurally, it is an 80S ribonucleoprotein complex composed of a small 40S subunit and a large 60S subunit, which together contain four ribosomal RNA (rRNA) molecules and approximately 80 ribosomal proteins. In oncology, the mammalian ribosome is a validated therapeutic target because rapidly proliferating cancer cells are highly dependent on elevated rates of protein synthesis to sustain their growth and biomass. Drugs like omacetaxine mepesuccinate (homoharringtonine) bind to the A-site cleft of the large ribosomal subunit, preventing the elongation step of translation and selectively inducing apoptosis in malignant cells, such as those in chronic myeloid leukemia (CML). Additionally, the ribosome can be targeted by translation readthrough-inducing drugs like ataluren, which interact with the decoding and peptidyl transferase centers to promote the suppression of premature stop codons, offering a therapeutic approach for genetic diseases caused by nonsense mutations.

Other names
Mammalian ribosomesEukaryotic ribosomeEukaryotic 80S ribosome80S ribosomeCytosolic ribosome
02

Mechanism of action

Inhibition of protein translation elongation by binding to the ribosomal A-site cleft and preventing the correct positioning of incoming aminoacyl-tRNAs (e.g., omacetaxine mepesuccinate); or suppression of nonsense mutations by promoting the readthrough of premature stop codons through interaction with the decoding center and peptidyl transferase center (e.g., ataluren).

03

Biological functions

Cell cycleCell proliferationCell deathOther
04

Disease associations

CancerInfectionOther
05

Safety considerations

Myelosuppression (neutropenia, thrombocytopenia, anemia)HyperglycemiaGastrointestinal toxicity (diarrhea, nausea, vomiting)Bleeding/hemorrhageImmunosuppressionOff-target toxicity due to general translation inhibition
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

BCR-ABL1 mutation statusPhiladelphia chromosomeNonsense mutations in DMD geneNonsense mutations in CFTR gene

Beyond the preview

Go deeper on Mammalian ribosome (80S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mammalian ribosome (80S ribosome).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call